Back to search results

Screening for Infectious Disease Research

This study is looking for healthy volunteers, aged 18 to 65, to potentially participate in future research on infectious diseases like Zika and Influenza. The goal is to collect blood (serum) and RNA samples, along with health information, to see if you might be a good fit for upcoming studies. These future studies aim to understand how viruses affect people and to help develop vaccines and treatments. For example, some studies might involve exposing participants to the flu virus to learn more about it. This is an ongoing study that has been open for 20 years, and they plan to enroll up to 5000 people. The study is considered successful if they find healthy volunteers for future research.

Study design
This is an observational study with a planned enrollment of 5000 participants, open for 20 years. It aims to find healthy volunteers for future research.
What's involved
The primary goal is to collect and store serum and RNA samples and obtain clinical and laboratory data from volunteers. The time commitment for a participant is measured at one time.
Compensation
Not stated in the trial record.
Follow-up
Participants are measured at one time for this screening study, which is part of a 20-year open study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01386424

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

Recruiting
Not specifiedAges 18–65Observational
National Institute of Allergy and Infectious Diseases (NIAID)
~5,000 participants
Updated 2026-08-28 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Find Healthy volunteers for research
Measured over One time for a participant, 20 year open study

Conditions

Zika
Influenza

Explore related trials

InfluenzaZika Virus Infection

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Matthew J Memoli, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Allergy and Infectious Diseases (NIAID)

Who to contact

Rani S Athota, Ph.D.
[email protected]
(301) 594-0803
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Of non-childbearing potential (i.e., women who have had a hysterectomy or tubal ligation or are post-menopausal, as defined by no menses in greater than or equal to 1 year)
Of childbearing potential but agrees to practice effective contraception or abstinence (from heterosexual sex) for 4 weeks prior to enrolling into a spceific study and during the study.

Exclusion

Chronic pulmonary disease (such as asthma, emphysema)
Chronic cardiovascular disease (cardiomyopathy, congestive heart failure, cardiac surgery, ischemic heart disease, known anatomic defects)
Chronic medical conditions requiring close medical follow-up or hospitalization during the past 5 years (diabetes mellitus, renal dysfunction, hemoglobinopathies)
Immunosuppression or cancer
Neurological and neuro-developmental conditions (e.g., cerebral palsy, epilepsy, stroke, seizures)
Drug and/or alcohol dependency and/or abuse 2. Any condition that, in the judgment of the Principal Investigator, is a contraindication to protocol participation or impairs the volunteer s ability to give informed consent

What this trial measures

  • Find Healthy volunteers for researchOne time for a participant, 20 year open study

    The primary goal of this study is to collect and store serum and RNAsamples and obtain clinical and laboratory data from volunteers todetermine in advance if they are potentially eligible to participate infuture LID Clincal Studies Unit protocols.